NPS PHARMACEUTICALS INC Forms 3, 4 and 5: Other
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 6 rows, 6 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2014-03-13: Reporting owner Friedman Robin D; Form 3; Security No securities are beneficially owned; Transaction Holding.
- 2014-03-07: Reporting owner Cvijic Christine Mikail; Form 3; Security No securities are beneficially owned; Transaction Holding.
- 2013-05-30: Reporting owner Graf Susan E; Form 3; Security No securities are benefically owned; Transaction Holding.
- 2012-09-17: Reporting owner Melrose Glenn R; Form 4/A; Security Common Stock; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2014-03-13 holding as of filing | Friedman Robin D Officer (SVP of Human Resources) | 3 | No securities are beneficially owned Non-derivative · Direct | Holding | 0 owned after | no price filed | 2014-03-13 | |
| 2014-03-07 holding as of filing | Cvijic Christine Mikail Officer (SVP, Legal Affairs & GC) | 3 | No securities are beneficially owned Non-derivative · Direct | Holding | 0 owned after | no price filed | 2014-03-07 | |
| 2013-05-30 holding as of filing | Graf Susan E Officer (VP of Corp Dev & Strategy) | 3 | No securities are benefically owned Non-derivative · Direct | Holding | 0 owned after | no price filed | 2013-05-30 | |
| 2012-09-17 | Melrose Glenn R Officer (SVP, Human Resources) | 4/A | Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +24,485 24,485 owned after | $4.59 | 2012-09-28 | |
| 2012-09-17 | Melrose Glenn R Officer (SVP, Human Resources) | 4 | Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +22,819 22,819 owned after | $4.93 | 2012-09-19 | |
| 2010-11-17 | GRANADILLO PEDRO P Director | 4 | Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +36,000 36,000 owned after | $6.25 exercise price | 2010-11-19 |